Top compounds associated with response to ADGRF2


Feature Type Standardized
Nominal ANOVA
mRNA Zibotentan GDSC1000 pan-cancer AAC -0.08 0.02
mRNA avicin D CTRPv2 pan-cancer AAC -0.13 0.02
mRNA PLX4720 GDSC1000 pan-cancer AAC 0.072 0.02
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA SB590885 GDSC1000 pan-cancer AAC 0.075 0.02
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.088 0.02
mRNA ML203 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.072 0.02
mRNA simvastatin CTRPv2 pan-cancer AAC -0.089 0.02
mRNA procarbazine CTRPv2 pan-cancer AAC 0.088 0.02
Download CSV